Comparatively, increased levels of ALT, AST, ALP, TB and BD in the cisplatin-treated group can be due to the depletion of hepatocyte and cellular stress, which altered the functional ability of endogenous enzyme heme-oxygenase-1 (HO-1) responsible for bilirubin production. The gene discussed is HMOX1; the disease is Behcet disease.